Biosense Webster, Inc., a worldwide leader in the diagnosis and
treatment of cardiac arrhythmias, has partnered with advocacy
organization StopAfib.org to encourage Americans to Get
SMART About Afib SM .
- Data suggest support for potential label expansion of XIAFLEX for Dupuytren's contracture to include treatment of two affected joints concurrently; PDUFA date is October 20, 2014 -
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.